newsfilter
← Latest News
GlobeNewswire·

Zentalis Pharmaceuticals Announces Poster Presentation at 2025 ASCO Annual Meeting

SAN DIEGO, April 23, 2025 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (NASDAQ:ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class WEE1 inhibitor for